Abstract
A new anti-cancer agent, misonidazole, is now available for investigational purposes. It is a radiation sensitiser, and a national trial is described for its use in the curative treatment of carcinoma of the bladder. The co-operation of doctors is sought in referring patients for this study.
Publication types
-
Clinical Trial
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Carcinoma / drug therapy*
-
Carcinoma / radiotherapy
-
Clinical Trials as Topic
-
Humans
-
Misonidazole / adverse effects
-
Misonidazole / therapeutic use*
-
Nausea / chemically induced
-
Neoplasm Staging
-
New Zealand
-
Nitroimidazoles / therapeutic use*
-
Urinary Bladder Neoplasms / drug therapy*
-
Urinary Bladder Neoplasms / radiotherapy
-
Vomiting / chemically induced
Substances
-
Nitroimidazoles
-
Misonidazole